Date | 10 March 2021 – present |
---|---|
Location | Angola |
Motive | COVID-19 pandemic in Angola |
COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines. [1] [2] 822,109 people with the first dose and 492,266 people fully vaccinated. [3] [4] Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021. [5] [6]
Vaccine | Ordered | Received | Approval | Deployment |
---|---|---|---|---|
Sputnik V | Yes | Yes | ||
Oxford–AstraZeneca | 2,177,000 | 624,000 | Yes | Yes |
Sinopharm BIBP | Yes | No | ||
Pfizer | 100,602 | 0 | No | No |
Sputnik Light | Yes | No | ||
On 2 March 2021, Angola received its first shipment of 624,000 of Oxford/Astrazeneca vaccine courtesy of COVAX. [7]
Mass vaccination started on 10 March. [8] By the end of the month 111,230 vaccine doses had been administered. [9]
Angola received 495,000 doses of the Oxford-AstraZeneca vaccine which the Democratic Republic of Congo had been unable to use before the expiry date. [10]
As of 23 April 2021, Angola had administered a total of 456,349 doses. [11] By the end of the month 513,000 persons had received an inoculation. [12] [13]
On 30 May, Angola received 25,000 doses of the Sputnik V COVID-19 vaccine donated by Russia. [14] [15]
By the end of the month 1.75 million doses had been administered, including 294,577 second doses. [16] [17]
On 1 June, Angola received 100,620 doses of the Pfizer–BioNTech COVID-19 vaccine purchased through COVAX. [16]
On 29 June, the Health Minister announced that due to a shortage of vaccine doses, first doses would be suspended until further notice while second doses would continue to be administered. [18]
By the end of the month, 1.5 million vaccine doses had been administered. [9]
By the end of the month, 1.7 million vaccine doses had been administered. [9]
On 26 August, Angola received 185,000 doses of the Oxford–AstraZeneca COVID-19 vaccine donated by Portugal, which has so far donated 370,000 vaccines to Angola. [19]
By the end of the month 1.9 million vaccine doses had been administered. [9]
On 27 September, Angola received 1.2 million doses of the Sinopharm BIBP vaccine through COVAX. [20]
By the end of the month 3.1 million vaccine doses had been administered. [9]
By the end of the month 6.2 million vaccine doses had been administered while 12% of the target population had been fully vaccinated. [9]
In late November, Angola received 453,600 doses of the Janssen COVID-19 vaccine courtesy of the Mastercard Foundation. [21]
By the end of the month 9.3 million vaccine doses had been administered while 21% of the target population had been fully vaccinated. [9]
By the end of the month 11 million vaccine doses had been administered while 28% of the target population had been fully vaccinated. [9]
By the end of the month 14.6 million vaccine doses had been administered while 35% of the target population had been fully vaccinated. [9]
By the end of the month 16.6 million vaccine doses had been administered while 5.6 million persons had been fully vaccinated. [9]
By the end of the month 17.7 million vaccine doses had been administered while 6.1 million persons had been fully vaccinated. [9]
By the end of the month 17.9 million vaccine doses had been administered while 6.3 million persons had been fully vaccinated. [9]
Cumulative vaccinations
Graphs are temporarily unavailable due to technical issues. |
8 Jun 2021 | 1,115,919 |
31 May 2021 | 909,215 |
26 May 2021 | 859,979 |
18 May 2021 | 681,502 |
12 May 2021 | 626,572 |
23 Apr 2021 | 456,349 |
19 Apr 2021 | 395,447 |
11 Apr 2021 | 245,442 |
29 Mar 2021 | 130,750 |
24 Mar 2021 | 87,022 |
18 Mar 2021 | 49,000, |
8 Mar 2021 | 6,169 |
5 Mar 2021 | 0 |
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.
The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.
COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
Burkina Faso started vaccinating against COVID-19 on 2 June 2021.
Cape Verde has begun vaccinations against COVID-19.
COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered. Africa received in total less than 2% of the 3 billion vaccination doses provided globally.
COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.
Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. The Sinopharm BIBP vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021, and Covaxin from Bharat Biotech on 10 November 2021.
COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.
COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.